Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 -6.106M
March 31, 2026 -6.324M
December 31, 2025 -6.146M
September 30, 2025 -6.153M
June 30, 2025 -5.738M
March 31, 2025 -5.542M
December 31, 2024 -5.397M
September 30, 2024 -6.203M
June 30, 2024 -6.077M
Date Value
March 31, 2024 -6.046M
December 31, 2023 -6.445M
September 30, 2023 -7.319M
June 30, 2023 -7.630M
March 31, 2023 -6.666M
December 31, 2022 -5.167M
September 30, 2022 -2.739M
June 30, 2022 -1.283M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Tenax Therapeutics, Inc. -46.03M
Exicure, Inc. -6.385M
Century Therapeutics, Inc. -88.07M
Absci Corp. -108.97M
Celularity, Inc. -8.814M